DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 2,074 filers reported holding DANAHER CORPORATION in Q4 2022. The put-call ratio across all filers is 1.10 and the average weighting 0.6%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,742,374 | +0.2% | 7,023 | -3.1% | 0.05% | 0.0% |
| Q2 2023 | $1,739,489 | +2.6% | 7,248 | +7.8% | 0.05% | -4.2% |
| Q1 2023 | $1,694,685 | +96794.5% | 6,724 | +2.0% | 0.05% | -4.0% |
| Q4 2022 | $1,749 | -99.9% | 6,590 | +1.7% | 0.05% | -3.8% |
| Q3 2022 | $1,673,000 | +0.4% | 6,478 | -1.4% | 0.05% | +10.6% |
| Q2 2022 | $1,666,000 | -20.1% | 6,573 | -7.5% | 0.05% | -7.8% |
| Q1 2022 | $2,084,000 | -17.0% | 7,104 | -7.0% | 0.05% | -15.0% |
| Q4 2021 | $2,512,000 | +7.7% | 7,635 | -0.3% | 0.06% | 0.0% |
| Q3 2021 | $2,332,000 | +13.7% | 7,660 | +0.2% | 0.06% | +11.1% |
| Q2 2021 | $2,051,000 | +19.0% | 7,643 | -0.2% | 0.05% | +12.5% |
| Q1 2021 | $1,723,000 | +1.4% | 7,656 | +0.1% | 0.05% | -12.7% |
| Q4 2020 | $1,700,000 | +2.4% | 7,649 | -0.8% | 0.06% | -16.7% |
| Q3 2020 | $1,660,000 | +23.3% | 7,708 | +1.3% | 0.07% | +17.9% |
| Q2 2020 | $1,346,000 | +45.4% | 7,610 | +13.7% | 0.06% | +30.2% |
| Q1 2020 | $926,000 | -9.8% | 6,692 | 0.0% | 0.04% | +13.2% |
| Q4 2019 | $1,027,000 | +6.1% | 6,692 | -0.2% | 0.04% | -9.5% |
| Q3 2019 | $968,000 | -10.5% | 6,703 | -11.4% | 0.04% | -14.3% |
| Q2 2019 | $1,082,000 | -1.5% | 7,569 | -9.0% | 0.05% | -2.0% |
| Q1 2019 | $1,098,000 | +30.4% | 8,314 | +1.7% | 0.05% | +25.0% |
| Q4 2018 | $842,000 | -3.1% | 8,173 | +2.2% | 0.04% | +21.2% |
| Q3 2018 | $869,000 | +7.4% | 7,996 | -2.4% | 0.03% | -5.7% |
| Q2 2018 | $809,000 | -3.0% | 8,196 | -3.7% | 0.04% | -7.9% |
| Q1 2018 | $834,000 | +46.6% | 8,513 | +38.6% | 0.04% | +26.7% |
| Q4 2017 | $569,000 | +31.1% | 6,140 | +21.2% | 0.03% | +20.0% |
| Q3 2017 | $434,000 | -7.5% | 5,065 | -8.9% | 0.02% | -16.7% |
| Q2 2017 | $469,000 | +1.3% | 5,561 | +2.8% | 0.03% | -3.2% |
| Q1 2017 | $463,000 | +19.9% | 5,411 | +9.2% | 0.03% | +10.7% |
| Q4 2016 | $386,000 | – | 4,956 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ARTHUR M. COHEN & ASSOCIATES, LLC | 217,436 | $53,823,432 | 13.80% |
| Defender Capital, LLC. | 152,962 | $37,949,802 | 13.74% |
| Bancreek Capital Management, LP | 60,890 | $15,106,809 | 13.58% |
| BOONE CAPITAL MANAGEMENT LLC | 129,163 | $32,045,340 | 10.11% |
| Eagle Health Investments LP | 175,085 | $43,438,589 | 9.57% |
| Third Point | 2,450,000 | $607,845,000 | 9.22% |
| Clio Asset Management LLC | 41,695 | $10,344,530 | 9.04% |
| Consulta Ltd | 500,000 | $124,050,000 | 8.91% |
| Riverstone Advisors, LLC | 47,960 | $11,799,701 | 8.16% |
| CADEN CAPITAL PARTNERS, LP | 123,755 | $27,215,377 | 7.66% |